Company Profiles

driven by the PitchBook Platform

AlloMek Therapeutics

Description

Developer of targeted therapies for cancer patients. The company develops an allosteric MEK kinase inhibitor that combines potent activity against MEK1/2 kinase and chemo-resistant ovarian cancer stem cells.

2010

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$250k

Latest Deal Amount

$670k

Total Amount Raised

2

Investors

Description

Developer of targeted therapies for cancer patients. The company develops an allosteric MEK kinase inhibitor that combines potent activity against MEK1/2 kinase and chemo-resistant ovarian cancer stem cells.

Website:

www.allomek.optimatrix.net

Formerly Known As

AlloStem Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

400 Farmington Avenue Farmington, CT 06032United States +1 (860) 679-6893
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AlloMek Therapeutics's full profile, request a free trial.

AlloMek Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AlloMek Therapeutics Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
Robert WolfeAngel (individual)Minority000 0000000 0000
Connecticut Innovations Venture Capital
Robert Wolfe Angel (individual)

AlloMek Therapeutics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Uday Khire Ph.DCo-Founder, Chief Executive Officer & Board Member
Barry Hart Ph.DCo-Founder, Project Manager and Director, Business Development
Uday Khire Ph.D Co-Founder, Chief Executive Officer & Board Member
Barry Hart Ph.D Co-Founder, Project Manager and Director, Business Development

AlloMek Therapeutics Board Members (2)

NameRepresentingRoleSinceContact
Info
Peter LongoConnecticut InnovationsSenior Managing Director, Investments000 0000
Uday Khire Ph.DAlloMek TherapeuticsCo-Founder, Chief Executive Officer & Board Member000 0000
Peter Longo Senior Managing Director, Investments Connecticut Innovations
Uday Khire Ph.D Co-Founder, Chief Executive Officer & Board Member AlloMek Therapeutics
Request full access to PitchBook